organization · Reporting owner
Madryn Asset Management, LP
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Greenbrook TMS Inc.GBNH · Entity 90446 | 10% owner | January 01, 2024 | January 11, 2024 |
| Neuronetics, Inc.STIM · Entity 6248 | 10% owner | May 28, 2026 | June 17, 2026 |
| Venus Concept Inc.VERO · Entity 55304 | 10% owner | March 26, 2026 | March 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Greenbrook TMS Inc.
Report date January 01, 2024 · Filed January 11, 2024
Jointly reported with Madryn Health Partners, LP, MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP, Madryn Select Opportunities, LP, MADRYN HEALTH ADVISORS II, LP, MADRYN HEALTH ADVISORS GP II, LLC, MADRYN SELECT ADVISORS, LP, MADRYN SELECT ADVISORS GP, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 6,363,636 |
Reported balance
Holding disclosure · report date 2024-01-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 6,363,636 F1: Represents securities held directly by Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and, in the case of the Common Share Conversion Instruments described in Table II, Madryn Select Opportunities, LP ("Select Opportunities" and together with Health Partners and Cayman Master, the "Funds"). Madryn Asset Management, LP ("Madryn"), as investment advisor for each of the Funds, and each of Madryn Health Advisors II, LP, Madryn Health Advisors GP II, LLC, Madryn Select Advisors, LP, and Madryn Select Advisors GP, LLC, as general partners for each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F2: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. F3: Health Partners and Cayman Master directly hold 393,459 and 5,970,177 shares of the Company's common stock ("Common Shares"), respectively. |
| Common Share Conversion InstrumentsSEC Table II · derivative / convertible security · Conversion / exercise price $1.90 · Expires 2027-09-30 | IndirectSee footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2024-01-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F4: Each of the Funds entered into a common share conversion instrument on July 14, 2022 (collectively, as amended and/or restated from time to time, the "Conversion Instruments") in connection with loans provided under the Company's senior secured credit facility with Madryn and its affiliates. F1: Represents securities held directly by Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and, in the case of the Common Share Conversion Instruments described in Table II, Madryn Select Opportunities, LP ("Select Opportunities" and together with Health Partners and Cayman Master, the "Funds"). Madryn Asset Management, LP ("Madryn"), as investment advisor for each of the Funds, and each of Madryn Health Advisors II, LP, Madryn Health Advisors GP II, LLC, Madryn Select Advisors, LP, and Madryn Select Advisors GP, LLC, as general partners for each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F2: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. F5: Health Partners, Cayman Master, and Select Opportunities may receive (a) 202,423, (b) 3,071,480 and (c) 636,701 Common Shares, respectively, upon the exercise of the Conversion Instruments. |
| Subordinated Convertible NotesSEC Table II · derivative / convertible security · Conversion / exercise price $0.22 · Expires 2028-03-31 | IndirectSee footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2024-01-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F6: On each of August 15, 2023, September 1, 2023, and October 12, 2023, Health Partners and Cayman Master acquired from the Company subordinated convertible promissory notes (the "Subordinated Convertible Notes"). F7: The Subordinated Convertible Notes are convertible at a price equal to the lesser of (a) 85% of the closing price per Common Shares on Nasdaq or any other market as of the closing date for such Subordinated Convertible Notes and (b)(i) 85% of the 30-day volume weighted average trading price of the Common Shares prior to conversion, or (ii) if the Common Shares are not listed on any of Nasdaq or another trading market at the time of conversion, a per share price based equal to 85% of the fair market value per Common Share as of such date; provided, that, in any event, the Subordinated Convertible Note conversion price shall not be lower than $0.078. The conversion price of the Subordinated Convertible Notes is also subject to customary anti-dilution adjustments F8: The conversion price of the Subordinated Convertible Notes issued on each of August 15, 2023 and September 1, 2023 is $0.2168. F1: Represents securities held directly by Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and, in the case of the Common Share Conversion Instruments described in Table II, Madryn Select Opportunities, LP ("Select Opportunities" and together with Health Partners and Cayman Master, the "Funds"). Madryn Asset Management, LP ("Madryn"), as investment advisor for each of the Funds, and each of Madryn Health Advisors II, LP, Madryn Health Advisors GP II, LLC, Madryn Select Advisors, LP, and Madryn Select Advisors GP, LLC, as general partners for each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F2: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. F9: With respect to the Subordinated Convertible Notes issued on August 15, 2023 and September 1, 2023, Health Partners and Cayman Master may convert such Subordinated Convertible Notes into an aggregate of 855,571 and 12,982,066 Common Shares, respectively. |
| Subordinated Convertible NotesSEC Table II · derivative / convertible security · Conversion / exercise price $0.23 · Expires 2028-03-31 | IndirectSee footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2024-01-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F6: On each of August 15, 2023, September 1, 2023, and October 12, 2023, Health Partners and Cayman Master acquired from the Company subordinated convertible promissory notes (the "Subordinated Convertible Notes"). F7: The Subordinated Convertible Notes are convertible at a price equal to the lesser of (a) 85% of the closing price per Common Shares on Nasdaq or any other market as of the closing date for such Subordinated Convertible Notes and (b)(i) 85% of the 30-day volume weighted average trading price of the Common Shares prior to conversion, or (ii) if the Common Shares are not listed on any of Nasdaq or another trading market at the time of conversion, a per share price based equal to 85% of the fair market value per Common Share as of such date; provided, that, in any event, the Subordinated Convertible Note conversion price shall not be lower than $0.078. The conversion price of the Subordinated Convertible Notes is also subject to customary anti-dilution adjustments F10: The conversion price of the Subordinated Convertible Notes issued on October 12, 2023 is $0.2315. F1: Represents securities held directly by Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and, in the case of the Common Share Conversion Instruments described in Table II, Madryn Select Opportunities, LP ("Select Opportunities" and together with Health Partners and Cayman Master, the "Funds"). Madryn Asset Management, LP ("Madryn"), as investment advisor for each of the Funds, and each of Madryn Health Advisors II, LP, Madryn Health Advisors GP II, LLC, Madryn Select Advisors, LP, and Madryn Select Advisors GP, LLC, as general partners for each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F2: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. F11: With respect to the Subordinated Convertible Notes issued on October 12, 2023, Health Partners and Cayman Master may convert such Subordinated Convertible Notes into an aggregate of 400,622 and 6,078,859 Common Shares, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents securities held directly by Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and, in the case of the Common Share Conversion Instruments described in Table II, Madryn Select Opportunities, LP ("Select Opportunities" and together with Health Partners and Cayman Master, the "Funds"). Madryn Asset Management, LP ("Madryn"), as investment advisor for each of the Funds, and each of Madryn Health Advisors II, LP, Madryn Health Advisors GP II, LLC, Madryn Select Advisors, LP, and Madryn Select Advisors GP, LLC, as general partners for each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds.
F2: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.
F3: Health Partners and Cayman Master directly hold 393,459 and 5,970,177 shares of the Company's common stock ("Common Shares"), respectively.
F4: Each of the Funds entered into a common share conversion instrument on July 14, 2022 (collectively, as amended and/or restated from time to time, the "Conversion Instruments") in connection with loans provided under the Company's senior secured credit facility with Madryn and its affiliates.
F5: Health Partners, Cayman Master, and Select Opportunities may receive (a) 202,423, (b) 3,071,480 and (c) 636,701 Common Shares, respectively, upon the exercise of the Conversion Instruments.
F6: On each of August 15, 2023, September 1, 2023, and October 12, 2023, Health Partners and Cayman Master acquired from the Company subordinated convertible promissory notes (the "Subordinated Convertible Notes").
F7: The Subordinated Convertible Notes are convertible at a price equal to the lesser of (a) 85% of the closing price per Common Shares on Nasdaq or any other market as of the closing date for such Subordinated Convertible Notes and (b)(i) 85% of the 30-day volume weighted average trading price of the Common Shares prior to conversion, or (ii) if the Common Shares are not listed on any of Nasdaq or another trading market at the time of conversion, a per share price based equal to 85% of the fair market value per Common Share as of such date; provided, that, in any event, the Subordinated Convertible Note conversion price shall not be lower than $0.078. The conversion price of the Subordinated Convertible Notes is also subject to customary anti-dilution adjustments
F8: The conversion price of the Subordinated Convertible Notes issued on each of August 15, 2023 and September 1, 2023 is $0.2168.
F9: With respect to the Subordinated Convertible Notes issued on August 15, 2023 and September 1, 2023, Health Partners and Cayman Master may convert such Subordinated Convertible Notes into an aggregate of 855,571 and 12,982,066 Common Shares, respectively.
F10: The conversion price of the Subordinated Convertible Notes issued on October 12, 2023 is $0.2315.
F11: With respect to the Subordinated Convertible Notes issued on October 12, 2023, Health Partners and Cayman Master may convert such Subordinated Convertible Notes into an aggregate of 400,622 and 6,078,859 Common Shares, respectively.
Neuronetics, Inc.
Report date May 28, 2026 · Filed June 17, 2026
Jointly reported with Madryn Health Partners II, LP, MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP, MADRYN HEALTH ADVISORS II, LP, MADRYN HEALTH ADVISORS GP II, LLC, Madryn Select Opportunities, LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 1,433,024 |
Reported balance
After 2026-05-28 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-05-28 · Other · Acquired 2,071 · Balance 1,433,024 F1: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F2: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F3: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 17,069,598 |
Reported balance
After 2026-05-28 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-05-28 · Other · Acquired 24,658 · Balance 17,069,598 F1: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F5: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. F3: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 2,264,439 |
Reported balance
After 2026-05-28 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-05-28 · Other · Acquired 3,271 · Balance 2,264,439 F1: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F6: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. F4: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F7: Madryn Select Advisors, LP ("Select Advisors"), as general partner of Select Opportunities, and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to beneficially own the shares held directly by Select Opportunities. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 1,435,958 |
Reported balance
After 2026-06-15 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-06-15 · Other · Acquired 2,934 · Balance 1,435,958 F8: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F2: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F3: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 17,104,530 |
Reported balance
After 2026-06-15 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2026-06-15 · Other · Acquired 34,932 · Balance 17,104,530 F8: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F5: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. F3: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 2,269,073 |
Reported balance
After 2026-06-15 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2026-06-15 · Other · Acquired 4,634 · Balance 2,269,073 F8: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F6: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. F4: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F7: Madryn Select Advisors, LP ("Select Advisors"), as general partner of Select Opportunities, and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to beneficially own the shares held directly by Select Opportunities. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting.
F2: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor.
F3: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master.
F4: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest.
F5: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor.
F6: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor.
F7: Madryn Select Advisors, LP ("Select Advisors"), as general partner of Select Opportunities, and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to beneficially own the shares held directly by Select Opportunities.
F8: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration.
Venus Concept Inc.
Report date March 26, 2026 · Filed March 31, 2026
Jointly reported with Madryn Health Partners (Cayman Master), LP, Madryn Health Advisors, LP, Madryn Health Partners, LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 37,547,373 |
Last balance in matching sequence
After 2026-03-26 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-03-26 · Purchase · Acquired 37,500,000 · Balance 37,510,186 F1: Pursuant to a Stock Purchase Agreement, dated March 26, 2026, by and among Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the Issuer, the Issuer sold to the Funds an aggregate of 37,500,000 shares of common stock for an aggregate purchase price of $1,500,000. F2: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Row 2 · 2026-03-26 · Purchase · Acquired 37,187 · Balance 37,547,373 F4: Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. ("HealthQuest"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder. F2: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. |
| Voting Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 1,500,000 |
Reported balance
After 2026-03-26 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-26 · Purchase · Acquired 1,500,000 · Balance 1,500,000 F5: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F6: Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000. F2: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. |
| Voting Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 1,835,000 |
Reported balance
After 2026-03-26 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-26 · Purchase · Acquired 335,000 · Balance 1,835,000 F5: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F4: Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. ("HealthQuest"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder. F2: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. |
| Senior Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 1,575,810 |
Reported balance
After 2026-03-26 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-26 · Purchase · Acquired 1,575,810 · Balance 1,575,810 F7: The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date. F6: Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000. F2: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. |
| Secured Subordinated Convertible NotesSEC Table II · derivative / convertible security · Conversion / exercise price $13.76 · Expires 2026-12-09 | IndirectSee footnotes | Not disclosed |
Reported balance
After 2026-03-26 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-26 · Purchase · Acquired Not disclosed · Balance Not disclosed F8: The secured subordinated convertible notes (the "Notes") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes. F6: Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000. F2: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a Stock Purchase Agreement, dated March 26, 2026, by and among Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the Issuer, the Issuer sold to the Funds an aggregate of 37,500,000 shares of common stock for an aggregate purchase price of $1,500,000.
F2: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds.
F3: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.
F4: Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. ("HealthQuest"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder.
F5: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date.
F6: Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000.
F7: The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date.
F8: The secured subordinated convertible notes (the "Notes") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 17, 2026 20:47 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 4,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 6 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,269,073 F8 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F6 · balance_after: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F7 · ownership.nature: Madryn Select Advisors, LP ("Select Advisors"), as general partner of Select Opportunities, and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to beneficially own the shares held directly by Select Opportunities. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:47 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 34,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 5 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 17,104,530 F8 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F5 · balance_after: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:47 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 2,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 4 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,435,958 F8 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of the Madryn Funds as provided for in the respective partnership agreement of each Madryn Fund. Each transfer was made for no consideration. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F2 · balance_after: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| May 28, 2026 Filed Jun 17, 2026 20:47 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 3,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,264,439 F1 · kind: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F6 · balance_after: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F7 · ownership.nature: Madryn Select Advisors, LP ("Select Advisors"), as general partner of Select Opportunities, and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to beneficially own the shares held directly by Select Opportunities. Read SEC document |
| May 28, 2026 Filed Jun 17, 2026 20:47 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 24,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 17,069,598 F1 · kind: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F5 · balance_after: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| May 28, 2026 Filed Jun 17, 2026 20:47 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 2,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274303 · ownership.xml · nonDerivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,433,024 F1 · kind: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F1 · balance_after: Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting. F2 · balance_after: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F3 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| March 26, 2026 Filed Mar 31, 2026 01:16 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseVoting Convertible Preferred Stock · Derivative | 335,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-132846 · ownership.xml · derivative · entry 6 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,835,000 Underlying: Common Stock · 20,301 shares Expires not disclosed F5 · derivative.exercise_price: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F4 · price: Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. ("HealthQuest"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder. F5 · derivative.exercise_date: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F5 · derivative.expiration_date: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F2 · ownership.nature: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 26, 2026 Filed Mar 31, 2026 01:16 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $13.76 | $2,611,228.33 |
DisclosureSEC source: 0001193125-26-132846 · ownership.xml · derivative · entry 5 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: Not disclosed Underlying: Common Stock · 189,756 shares Expires 2026-12-09 F8 · derivative.exercise_price: The secured subordinated convertible notes (the "Notes") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes. F6 · price: Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000. F8 · derivative.exercise_date: The secured subordinated convertible notes (the "Notes") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes. F8 · derivative.expiration_date: The secured subordinated convertible notes (the "Notes") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes. F2 · ownership.nature: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 26, 2026 Filed Mar 31, 2026 01:16 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSenior Convertible Preferred Stock · Derivative | 1,575,810 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-132846 · ownership.xml · derivative · entry 4 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,575,810 Underlying: Common Stock · 381,976 shares Expires not disclosed F7 · derivative.exercise_price: The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date. F6 · price: Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000. F7 · derivative.exercise_date: The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date. F7 · derivative.expiration_date: The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date. F2 · ownership.nature: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 26, 2026 Filed Mar 31, 2026 01:16 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseVoting Convertible Preferred Stock · Derivative | 1,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-132846 · ownership.xml · derivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,500,000 Underlying: Common Stock · 90,900 shares Expires not disclosed F5 · derivative.exercise_price: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F6 · price: Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000. F5 · derivative.exercise_date: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F5 · derivative.expiration_date: The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date. F2 · ownership.nature: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 26, 2026 Filed Mar 31, 2026 01:16 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseCommon Stock | 37,187 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-132846 · ownership.xml · nonDerivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 37,547,373 F4 · price: Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. ("HealthQuest"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder. F2 · ownership.nature: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 26, 2026 Filed Mar 31, 2026 01:16 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseCommon Stock | 37,500,000 | $0.04 | $1,500,000.00 |
DisclosureSEC source: 0001193125-26-132846 · ownership.xml · nonDerivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 37,510,186 F1 · price: Pursuant to a Stock Purchase Agreement, dated March 26, 2026, by and among Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the Issuer, the Issuer sold to the Funds an aggregate of 37,500,000 shares of common stock for an aggregate purchase price of $1,500,000. F2 · ownership.nature: Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 23:23 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSeries Y Convertible Preferred Stock · Derivative | 545,335 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-228849 · ownership.xml · derivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,030,866 Underlying: Common Stock · 4,957,587 shares Expires not disclosed F6 · derivative.exercise_price: Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions. F3 · price: The reported transactions involved an exchange of secured subordinated convertible notes in the aggregate principal amount of $11,479,307.35 (the "Notes") for 545,335 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F7 · derivative.expiration_date: The Series Y Preferred Stock is perpetual and therefore has no expiration date. F6 · derivative.underlying_shares: Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions. F4 · balance_after: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 23:23 UTC | Venus Concept Inc. VERO · Entity 55304 | Disposition to issuerSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $264.00 | $11,479,307.35 |
DisclosureSEC source: 0001193125-25-228849 · ownership.xml · derivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 43,482 shares Expires 2026-12-09 F1 · derivative.exercise_price: The Notes (as defined below) were convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of Notes. F2 · reported_value: The principal amount of subordinated convertible notes disposed of represents (x) $11,096,478.80, the initial principal balance of the subordinated convertible notes disclosed on a Form 4 filed by the Reporting Persons on July 2, 2025, plus (y) $382,828.52 of interest paid-in-kind on September 30, 2025. F3 · price: The reported transactions involved an exchange of secured subordinated convertible notes in the aggregate principal amount of $11,479,307.35 (the "Notes") for 545,335 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F1 · derivative.underlying_shares: The Notes (as defined below) were convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of Notes. F2 · derivative.underlying_shares: The principal amount of subordinated convertible notes disposed of represents (x) $11,096,478.80, the initial principal balance of the subordinated convertible notes disclosed on a Form 4 filed by the Reporting Persons on July 2, 2025, plus (y) $382,828.52 of interest paid-in-kind on September 30, 2025. F4 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 381,640 | $3.72 | $1,419,700.80 |
DisclosureSEC source: 0000950170-25-107329 · ownership.xml · nonDerivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner MADRYN SELECT ADVISORS, LP · CIK 0002007794 · 10% owner MADRYN SELECT ADVISORS GP, LLC · CIK 0002007745 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,261,168 F2 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Madryn Health Partners II (Cayman Master), LP ("Cayman Master"); Madryn Health Advisors GP II, LLC, as general partner of Health Advisors; Madryn Select Advisors, LP ("Select Advisors") as general partner of Madryn Select Opportunities, LP ("Select Opportunities"); and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners, Cayman Master and Select Advisors, respectively. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F5 · ownership.nature: Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 2,925,554 | $3.72 | $10,883,060.88 |
DisclosureSEC source: 0000950170-25-107329 · ownership.xml · nonDerivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner MADRYN SELECT ADVISORS, LP · CIK 0002007794 · 10% owner MADRYN SELECT ADVISORS GP, LLC · CIK 0002007745 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 17,333,542 F2 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Madryn Health Partners II (Cayman Master), LP ("Cayman Master"); Madryn Health Advisors GP II, LLC, as general partner of Health Advisors; Madryn Select Advisors, LP ("Select Advisors") as general partner of Madryn Select Opportunities, LP ("Select Opportunities"); and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners, Cayman Master and Select Advisors, respectively. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F4 · ownership.nature: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 192,806 | $3.72 | $717,238.32 |
DisclosureSEC source: 0000950170-25-107329 · ownership.xml · nonDerivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Madryn Select Opportunities, LP · CIK 0001889283 · 10% owner MADRYN SELECT ADVISORS, LP · CIK 0002007794 · 10% owner MADRYN SELECT ADVISORS GP, LLC · CIK 0002007745 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,142,351 F1 · ownership.nature: Represents shares of common stock held by Madryn Health Partners II, LP ("Health Partners"), for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F2 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Madryn Health Partners II (Cayman Master), LP ("Cayman Master"); Madryn Health Advisors GP II, LLC, as general partner of Health Advisors; Madryn Select Advisors, LP ("Select Advisors") as general partner of Madryn Select Opportunities, LP ("Select Opportunities"); and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners, Cayman Master and Select Advisors, respectively. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| July 10, 2025 Filed Apr 1, 2026 20:57 UTC | Neuronetics, Inc. STIM · Entity 6248 | GiftCommon Stock | 337,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-138142 · ownership.xml · nonDerivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 17,044,940 F1 · price: The reported transactions involved a transfer of shares for no consideration between Madryn Health Partners II, LP ("Health Partners") and Madryn Health Partners II (Cayman Master), LP ("Cayman Master") for fund administration purposes. F2 · balance_after: Represents shares of common stock held as of the date of filing of this Form 4. F4 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master; and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners and Cayman Master, respectively. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. F6 · ownership.nature: Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor. Read SEC document |
| July 10, 2025 Filed Apr 1, 2026 20:57 UTC | Neuronetics, Inc. STIM · Entity 6248 | GiftCommon Stock | 337,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-138142 · ownership.xml · nonDerivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners II, LP · CIK 0001919858 · 10% owner MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP · CIK 0002007791 · 10% owner MADRYN HEALTH ADVISORS II, LP · CIK 0002007977 · 10% owner MADRYN HEALTH ADVISORS GP II, LLC · CIK 0002007801 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,430,953 F1 · price: The reported transactions involved a transfer of shares for no consideration between Madryn Health Partners II, LP ("Health Partners") and Madryn Health Partners II (Cayman Master), LP ("Cayman Master") for fund administration purposes. F2 · balance_after: Represents shares of common stock held as of the date of filing of this Form 4. F3 · ownership.nature: Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor. F4 · ownership.nature: Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master; and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners and Cayman Master, respectively. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:27 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSeries Y Convertible Preferred Stock · Derivative | 325,651 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-093416 · ownership.xml · derivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,485,531 Underlying: Common Stock · 2,960,461 shares Expires not disclosed F5 · derivative.exercise_price: Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise. F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $17,015,808.30 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $11,096,478.80 (the "New Notes") and (ii) 325,651 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F6 · derivative.expiration_date: The Series Y Preferred Stock is perpetual and therefore has no expiration date. F5 · derivative.underlying_shares: Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise. F5 · balance_after: Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise. F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:27 UTC | Venus Concept Inc. VERO · Entity 55304 | Disposition to issuerSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $264.00 | $17,015,808.30 |
DisclosureSEC source: 0000950170-25-093416 · ownership.xml · derivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 64,454 shares Expires 2026-12-09 F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $17,015,808.30 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $11,096,478.80 (the "New Notes") and (ii) 325,651 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:27 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $264.00 | $11,096,478.80 |
DisclosureSEC source: 0000950170-25-093416 · ownership.xml · derivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: Not disclosed Underlying: Common Stock · 42,032 shares Expires 2026-12-09 F1 · derivative.exercise_price: The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes. F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $17,015,808.30 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $11,096,478.80 (the "New Notes") and (ii) 325,651 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F1 · derivative.underlying_shares: The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes. F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:47 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSeries Y Convertible Preferred Stock · Derivative | 379,311 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-049649 · ownership.xml · derivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,159,880 Underlying: Common Stock · 3,448,279 shares Expires not disclosed F6 · derivative.exercise_price: The number of shares of Common Stock underlying the Series Y Preferred Stock gives effect to the Reverse Stock Split. Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions. F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $28,015,827.33 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $17,015,808.33 (the "New Notes") and (ii) 379,311 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F7 · derivative.expiration_date: The Series Y Preferred Stock is perpetual and therefore has no expiration date. F6 · derivative.underlying_shares: The number of shares of Common Stock underlying the Series Y Preferred Stock gives effect to the Reverse Stock Split. Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions. F6 · balance_after: The number of shares of Common Stock underlying the Series Y Preferred Stock gives effect to the Reverse Stock Split. Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions. F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:47 UTC | Venus Concept Inc. VERO · Entity 55304 | Disposition to issuerSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $264.00 | $28,015,827.33 |
DisclosureSEC source: 0000950170-25-049649 · ownership.xml · derivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: Not disclosed Underlying: Common Stock · 106,121 shares Expires 2026-12-09 F5 · derivative.exercise_price: The Existing Notes were convertible at a rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on March 3, 2025 based on a one-for-eleven consolidation ratio (the "Reverse Stock Split"). F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $28,015,827.33 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $17,015,808.33 (the "New Notes") and (ii) 379,311 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F5 · derivative.underlying_shares: The Existing Notes were convertible at a rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on March 3, 2025 based on a one-for-eleven consolidation ratio (the "Reverse Stock Split"). F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:47 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $264.00 | $17,015,808.33 |
DisclosureSEC source: 0000950170-25-049649 · ownership.xml · derivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: Not disclosed Underlying: Common Stock · 64,454 shares Expires 2026-12-09 F1 · derivative.exercise_price: The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes. F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $28,015,827.33 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $17,015,808.33 (the "New Notes") and (ii) 379,311 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock"). F1 · derivative.underlying_shares: The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes. F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| September 26, 2024 Filed Oct 1, 2024 00:20 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSeries Y Convertible Preferred Stock · Derivative | 203,583 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-110494 · ownership.xml · derivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 780,569 Underlying: Common Stock · 20,358,300 shares Expires not disclosed F1 · derivative.exercise_price: Each share of the Company's Series Y Convertible Preferred Stock (the "Series Y Preferred Stock") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise. F3 · price: The reported transaction involved an exchange of $15,000,000 of existing senior secured indebtedness for 203,583 shares of Series Y Preferred Stock. F2 · derivative.expiration_date: The Series Y Preferred Stock is perpetual and therefore has no expiration date. F1 · derivative.underlying_shares: Each share of the Company's Series Y Convertible Preferred Stock (the "Series Y Preferred Stock") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise. F4 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| May 24, 2024 Filed May 29, 2024 22:58 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSeries Y Convertible Preferred Stock · Derivative | 576,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-066139 · ownership.xml · derivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 576,986 Underlying: Common Stock · 57,698,600 shares Expires not disclosed F1 · derivative.exercise_price: Each share of the Company's Series Y Convertible Preferred Stock (the "Series Y Preferred Stock") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise. F3 · price: The reported transaction involved an exchange of $35,000,000 of existing senior secured indebtedness for 576,986 shares of newly-created convertible preferred stock of the Company, designated as "Series Y Convertible Preferred Stock". F2 · derivative.expiration_date: The Series Y Preferred Stock is perpetual and therefore has no expiration date. F1 · derivative.underlying_shares: Each share of the Company's Series Y Convertible Preferred Stock (the "Series Y Preferred Stock") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise. F4 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F5 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:15 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSeries X Convertible Preferred Stock · Derivative | 248,755 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-052401 · ownership.xml · derivative · entry 3 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 248,755 Underlying: Common Stock · 2,487,550 shares Expires not disclosed F6 · derivative.exercise_price: Each share of Series X Convertible Preferred Stock is convertible into ten shares of Common Stock at any time at the option of the holder. F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $26,695,110.58 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $22,791,748.32 (the "New Notes") and (ii) 248,755 shares of Series X Convertible Preferred Stock. F7 · derivative.expiration_date: The Series X Convertible Preferred Stock is perpetual and therefore has no expiration date. F6 · derivative.underlying_shares: Each share of Series X Convertible Preferred Stock is convertible into ten shares of Common Stock at any time at the option of the holder. F5 · balance_after: The Existing Notes were convertible at a rate of 20.5128205 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on May 11, 2023 based on a one-for-fifteen consolidation ratio. F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:15 UTC | Venus Concept Inc. VERO · Entity 55304 | Disposition to issuerSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $48.75 | $26,695,110.58 |
DisclosureSEC source: 0000950170-23-052401 · ownership.xml · derivative · entry 2 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: Not disclosed Underlying: Common Stock · 547,593 shares Expires 2025-12-09 F5 · derivative.exercise_price: The Existing Notes were convertible at a rate of 20.5128205 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on May 11, 2023 based on a one-for-fifteen consolidation ratio. F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $26,695,110.58 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $22,791,748.32 (the "New Notes") and (ii) 248,755 shares of Series X Convertible Preferred Stock. F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:15 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseSecured Subordinated Convertible Notes · Derivative | Not disclosed | Not disclosed Strike: $24.00 | $22,791,748.32 |
DisclosureSEC source: 0000950170-23-052401 · ownership.xml · derivative · entry 1 Madryn Asset Management, LP · CIK 0001787423 · 10% owner Madryn Health Partners, LP · CIK 0001650490 · 10% owner Madryn Health Partners (Cayman Master), LP · CIK 0001836788 · 10% owner Madryn Health Advisors, LP · CIK 0001836559 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: Not disclosed Underlying: Common Stock · 949,657 shares Expires 2025-12-09 F1 · derivative.exercise_price: The New Notes (as defined below) are convertible at any time into shares of Common Stock at a conversion rate of 41.6666667 shares of Common Stock for each $1,000 principal amount of New Notes. F2 · price: The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $26,695,110.58 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $22,791,748.32 (the "New Notes") and (ii) 248,755 shares of Series X Convertible Preferred Stock. F1 · derivative.underlying_shares: The New Notes (as defined below) are convertible at any time into shares of Common Stock at a conversion rate of 41.6666667 shares of Common Stock for each $1,000 principal amount of New Notes. F3 · ownership.nature: Represents securities held directly by Madryn Health Partners, LP ("Health Partners LP") and Madryn Health Partners (Cayman Master), LP ("Cayman Master LP" and together with Health Partners LP, the "Funds"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds. F4 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.